NitiNotes
Caesarea
About NitiNotes
Nitinotes has developed the EndoZip™, a fully automated, gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction to help obese patients reduce weight.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2024)
- Website: nitinotesurgical.com
- Phone: +97246044996
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nitinotes-45413 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.